Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Archives of Pharmacal Research|July 8, 2010
Synthesis and preliminary antibacterial evaluation of 2-butyl succinate-based hydroxamate derivatives containing isoxazole ringsDatong Zhang, Jiong Jia, Lijuan Meng, et al.Molecules (Basel, Switzerland)|October 14, 2022
Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal StructureWenqing Jia, Shuyu Luo, Wennan Zhao, et al.Chinese Medicine|April 3, 2009
Effects of Astragaloside IV on heart failure in ratsZhuanyou Zhao, Weiting Wang, Fang Wang, et al.Diabetes Research and Clinical Practice|January 31, 2012
Formation of cyclic structure at amino-terminus of glucagon-like peptide-1 exhibited a prolonged half-life in vivoZhenghong Cao, Ying Li, Lida Tang, et al.Journal of Pharmaceutical and Biomedical Analysis|June 23, 2019
Comparative research on the metabolism of metoprolol by four CYP2D6 allelic variants in vitro with LC-MS/MSQingqing Yang, Jing Sun, Chuan Li, et al.Molecules (Basel, Switzerland)|April 19, 2016
Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological EvaluationWenzhi Wang, Jing Yuan, Xiaoli Fu, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 5, 2017
Comparative study on the interaction between 3 CYP2C9 allelic isoforms and benzbromarone by using LC-MS/MS methodLingli He, Chuan Li, Xuyuan Liu, et al.Oncotarget|April 19, 2017
Synthesis and evaluation of anthranilamide-based derivatives as FXa inhibitorsChangjiang Huang, Wenzhi Wang, Yao Li, et al.Molecules (Basel, Switzerland)|February 1, 2018
Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) InhibitorWenqing Cai, Jingwei Wu, Wei Liu, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|September 25, 2013
Discovery of 6-deoxydapagliflozin as a highly potent sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetesLingyu Zhang, Yuli Wang, Huaqiang Xu, et al.Pageof 4